News PharmaC2C.com

Pharma Biotech News

Menu

  • HOME

Fibrocell Science

Fibrocell Reports on Interim Results and Progress of Phase 1/2 Clinical Trial of FCX-007 Gene Therapy for Recessive Dystrophic Epidermolysis Bullosa

Fibrocell Reports on Interim Results and Progress of Phase 1/2 Clinical Trial of FCX-007 Gene Therapy for Recessive Dystrophic Epidermolysis Bullosa

May 21, 2018 – FCX-007 well-tolerated up to 52 weeks post-administration – – Continued positive trends noted in wound healing and pharmacology signals, including  type VII collagen expression and evidence of anchoring fibrils – – Company to Host Conference Call

Share this:

  • Click to share on Twitter (Opens in new window)
  • Click to share on Facebook (Opens in new window)
  • Click to share on LinkedIn (Opens in new window)
  • Click to share on WhatsApp (Opens in new window)
  • Click to print (Opens in new window)
NewsPharmaC2C May 21, 2018May 29, 2018 Fibrocell Science Read more

Categories

  • .FDA
    • Novel Drug Approvals
      • Novel Drug Approvals for 2015
      • Novel Drug Approvals for 2016
      • Novel Drug Approvals for 2017
      • Novel Drug Approvals for 2018
  • 4D Pharma Plc
  • Abbvie
  • Acadia Pharma
  • Acceleron
  • Achaogen
  • Achillion
  • Aclaris Therapeutics
  • Acorda Therapeutics
  • Adamas Pharmaceuticals
  • Adaptimmune Therapeutics
  • Aduro Biotech
  • Aerie Pharmaceuticals
  • Agios Pharmaceuticals
  • Aimmune Therapeutics
  • Akcea Therapeutics
  • Akebia Therapeutics
  • Alder BioPharmaceuticals
  • Alexion
  • Allergan
  • American Society of Hematology
  • Amgen
  • Aminex Therapeutics, Inc.
  • Array BioPharma Inc.
  • Astellas Pharma
  • AstraZeneca
  • Bayer
  • Beactica AB
  • Bellicum Pharmaceuticals
  • BERG
  • BerGenBio
  • Berlin Cures
  • Bicycle Therapeutics
  • Bio Products Laboratory
  • Biocept, Inc
  • BioCryst Pharmaceuticals
  • Biogen
  • BioMarin
  • Blueprint Medicines Corporation
  • Boehringer Ingelheim
  • Boston Biomedical
  • BrainStorm Cell Therapeutics
  • Bristol-Myers Squibb (BMS)
  • BTG
  • c-LEcta
  • Cannabics Pharmaceuticals
  • Cara Therapeutics
  • Caris Life Sciences
  • CEFALY Technology
  • Celgene
  • Champions Oncology, Inc.
  • Cingulate Therapeutics
  • Compugen
  • CSL Behring
  • Curis
  • Dendreon
  • Depomed
  • Diabetes Technology Society
  • DreaMed Diabetes
  • Eisai
  • Elekta
  • Eli Lilly
  • Elios Therapeutics
  • Elucida Oncology, Inc.
  • Emergent BioSolutions
  • Epigen Biosciences
  • EpiVax Oncology, Inc.
  • Eurocine Vaccines
  • European Hematology Association
  • Evofem Biosciences
  • Evotec
  • F-star
  • Fibrocell Science
  • Forty Seven
  • Genmab
  • GenomeDx Biosciences
  • Gilead Sciences
  • GlaxoSmithKline
  • Glenmark Pharmaceuticals
  • Grifols
  • GT Biopharma
  • GTx
  • Halozyme Therapeutics
  • Homology Medicines
  • Hygieia
  • Hyundai Hope On Wheels
  • Impel NeuroPharma
  • Indivior
  • IO Biotech
  • Ionis Pharmaceuticals
  • Iterum Therapeutics
  • Jazz Pharmaceuticals
  • Johnson & Johnson (J&J)
  • Kannalife Sciences
  • Kazia Therapeutics Limited
  • Legend Biotech
  • Leo Pharma
  • Lion TCR
  • Marapharm Ventures
  • MaxCyte
  • Medivir AB
  • MEI Pharma
  • Merck & Co. (US)
  • Merck KGaA (Germany)
  • Mylan
  • Nektar Therapeutics
  • NeuroVive Pharmaceutical
  • Nordic Nanovector
  • Novartis
  • Novo Nordisk
  • Octapharma AG
  • Oncternal Therapeutics
  • Oramed Pharmaceuticals
  • Orphazyme
  • Otsuka Holdings
  • Pfizer
  • PharmaBoardroom
  • Pharmaceutical Care Management Association
  • PharmaMar
  • Prevacus
  • Profectus BioSciences
  • ProMetic Life Sciences
  • PTC Therapeutics
  • Realm Therapeutics
  • Reata Pharmaceuticals
  • Regeneron
  • REGENXBIO
  • Replimune
  • Retrophin
  • Revance Therapeutics
  • Rigel Pharmaceuticals
  • Roche
  • Rocket Pharmaceuticals
  • RXi Pharmaceuticals
  • Sage Therapeutics
  • Sangamo Therapeutics
  • Sanofi
  • Sarepta Therapeutics
  • Savara Pharmaceuticals
  • Seattle Genetics
  • Seres Therapeutics
  • Shire
  • Sienna Biopharmaceuticals
  • Sierra Oncology
  • Sobi
  • Spark Therapeutics
  • Spectrum Pharmaceuticals
  • Spherix Global Insights
  • Steba Biotech
  • Stratus Pharmaceuticals
  • Strongbridge Biopharma
  • Supernus Pharmaceuticals
  • Syndax Pharmaceuticals
  • Synergy Pharmaceuticals
  • Takeda
  • TapImmune
  • Targovax
  • Tenax Therapeutics
  • Tesaro
  • Teva
  • TherapeuticsMD
  • Theravance Biopharma
  • Tolero Pharmaceuticals
  • Trianni
  • TrioxBio
  • Trovagene, Inc.
  • UCB
  • Ultragenyx Pharma
  • Us fda
  • Valeant Pharmaceuticals
  • Vanda Pharmaceuticals
  • Vertex Pharma
  • ViaCyte
  • ViewRay, Inc.
  • ViiV Healthcare
  • Visiongain
  • Wize Pharma
  • Zealand Pharma
  • Zogenix
  • Zymeworks
February 2019
M T W T F S S
« Jul    
 123
45678910
11121314151617
18192021222324
25262728  

Archives

  • July 2018
  • June 2018
  • May 2018
  • April 2018
  • March 2018
  • February 2018
  • January 2018
  • December 2017
  • December 2016
  • December 2015
  • HOME

© 2018 - Developed by Naffys Mir, Inc.